China News Service, February 10. According to the website of the National Medical Products Administration, as of February 10, 2021, the National Medical Products Administration has approved 56 new coronavirus detection reagents, including 26 nucleic acid detection reagents and 27 Antibody detection reagents, 3 antigen detection reagents; nucleic acid detection reagents with a daily production capacity of 6.656 million copies, antibody detection reagents with a daily production capacity of 16.46 million copies, antigen detection reagents with a daily production capacity of 1.903 million copies, with a cumulative daily production capacity of 25.019 million copies.
Data map: "Six Respiratory Virus Nucleic Acid Test Kits" coming out of the factory in the packaging workshop.
Photo by China News Agency reporter Liu Zhongjun
In addition, on February 9, 2021, the National Medical Products Administration approved the Zhuhai Livzon Reagent Co., Ltd. new coronavirus (2019-nCoV) IgM antibody detection kit (enzyme-linked immunoassay) and Chengdu Boao Jingxin Bio Technology Co., Ltd. automatic nucleic acid analyzer, new coronavirus 2019-nCoV nucleic acid detection kit (fully integrated dish chip method).